ABLEXIS
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.
ABLEXIS
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ablexis.com
Total Employee:
1+
Status:
Active
Contact:
(415) 967-1220
Email Addresses:
[email protected]
Total Funding:
12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Tag Manager WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Third Rock Ventures
Third Rock Ventures investment in Series A - Ablexis
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Ablexis
Official Site Inspections
http://www.ablexis.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: ablexis.com
- IP address: 72.52.86.106
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ablexis"
Ablexis - Crunchbase Company Profile & Funding
Organization. Ablexis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Ablexis, LLC, a biotechnology company dedicated to …See details»
About - Ablexis Ablexis A superior, next generation …
AlivaMab Biologics leverages the AlivaMab Mouse, developed by Ablexis as the platform for discovery projects conducted on behalf of clients. AlivaMab Biologics was established as a company separate from Ablexis in response to many …See details»
Contact - Ablexis Ablexis A superior, next generation transgenic …
[email protected] phone 415.967.1220 Delivering a superior, next generation platform for the discovery of therapeutic antibodies. ... Organization * Email * Phone . Message * Ablexis …See details»
Ablexis Company Profile 2024: Valuation, Funding & Investors
Ablexis was founded in 2009. Where is Ablexis headquartered? Ablexis is headquartered in San Diego, CA. What industry is Ablexis in? Ablexis’s primary industry is Other Healthcare …See details»
Ablexis, LLC - LinkedIn
Ablexis offers the AlivaMab® Mouse platform, a suite of transgenic mouse strains for human therapeutic antibody discovery. AlivaMab Mouse strains are uniquely designed to be better for human ...See details»
Ablexis Company Profile - Office Locations, Competitors ... - Craft
Ablexis is a company that commercializes a transgenic mouse platform AlivaMab for human therapeutic antibody discovery. It offers synthetic, autonomously functioning heavy, kappa, …See details»
Ablexis - Contacts, Employees, Board Members, Advisors & Alumni
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Integrated therapeutic antibody discovery solutions
Ablexis, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, and AlivaMab Discovery Services (ADS), a contract research organization ...See details»
Ablexis Secures $12 Million in Series A Funding to Engineer and ...
Jun 2, 2010 Ablexis, LLC was founded in December 2009 and is based on technology established by Aliva Biopharmaceuticals, Inc., which was founded in 2001 by Hiroaki Shizuya, …See details»
Ablexis and AlivaMab Discovery Services Announce …
Nov 15, 2022 Ablexis has license agreements with dozens of companies, including global pharmaceutical companies, public and private biotechnology companies and other entities. Ablexis continues making AlivaMab ...See details»
Ablexis and AlivaMab Discovery Services Announce ... - AlivaMab …
SAN DIEGO, Calif. – November 15, 2022 – Ablexis, LLC (“Ablexis”), a biopharmaceutical company focused on licensing its AlivaMab ® Mouse technology for antibody drug discovery, …See details»
Almirall announces multi-target licensing agreement with Ablexis …
Jan 31, 2022 BARCELONA, Spain and SAN DIEGO, Calif., USA, January 31, 2022 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced a …See details»
Ablexis and AlivaMab Discovery Services - Nature
Ablexis remains focused on supporting our partners’ success in discovering and developing new antibody drugs”, Green concluded. ... ADS is the only organization that combines the AlivaMab ...See details»
Ablexis Targets Market Expansion Opportunities for AlivaMab …
AlivaMab Discovery Services, an independent contract research organization, founded to provide clients a best in class source of therapeutic antibody candidates BURLINGAME, CA and NEW …See details»
Ablexis Targets Market Expansion Opportunities for AlivaMab …
Jun 21, 2018 The acquisition of Ablexis by Deerfield and the founding of AlivaMab Discovery Services support Ablexis in enabling biopharma companies of all sizes, from global pharma to …See details»
Ablexis and AlivaMab Discovery Services Announce Agreements …
Ablexis, LLC created and non-exclusively licenses AlivaMab Mouse, a suite of unique, patented next generation transgenic mice, as a platform for human therapeutic antibody discovery. …See details»
Ablexis and AlivaMab Discovery Services Announce Expansion of …
Nov 15, 2022 New platforms and capabilities further enable partners to advance better antibody drugs faster. SAN DIEGO, Calif. – November 15, 2022 – Ablexis, LLC (“Ablexis”), a …See details»
Ablexis and AlivaMab Discovery Services Announce Agreements …
Jan 31, 2022 Ablexis’ multi-target licensing agreement grants Almirall rights to use the AlivaMab® Mouse technology for research, development and commercialization of antibodies. …See details»
Ablexis, AlivaMab Discovery Services, and Berkeley Lights …
Apr 22, 2020 Ablexis has non-exclusively licensed the AlivaMab Mouse technology to multiple companies, including global pharmaceutical companies, public and private biotechnology …See details»